SEC Form SC 13G/A filed by NewHold Investment Corp. II (Amendment)
$NHIC
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/29/2021 | $16.00 | Outperform | Northland Capital Markets |
Northland Capital Markets initiated coverage of NewHold Investment with a rating of Outperform and set a new price target of $16.00
3 - NewHold Investment Corp. III (0002043699) (Issuer)
3 - NewHold Investment Corp. III (0002043699) (Issuer)
3 - NewHold Investment Corp. III (0002043699) (Issuer)
ASNR considers as satisfactory the safety program proposed by newcleo for its planned MOX fuel facility. The Company will incorporate the insights gained through the ASNR opinion in the ongoing development and planning of its project.SGPI informs the Company that the amount of money raised by newcleo along with its level of development has surpassed the scope of the France 2030 program, leading to different forms of collaboration with French institutions. PARIS, July 17, 2026 (GLOBE NEWSWIRE) -- newcleo (or the "Company"), a pioneer in advanced modular reactor ("AMR") technology and nuclear fuel manufacturing, today announced a significant regulatory milestone for its planned mixed-oxide
Proposed Nasdaq listing under ticker symbol NWCL in connection with business combination The transaction is expected to be completed in the second half of 2026, subject to customary closing conditions. PARIS and NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- NewHold Investment Corp. III (NASDAQ:NHIC) ("NewHold"), and newcleo Ltd. ("newcleo"), a pioneer in advanced modular reactor ("AMR") technology and nuclear fuel manufacturing, today announced that newcleo filed a registration statement on Form F-4 (as may be amended, the "Registration Statement") with the U.S. Securities and Exchange Commission ("SEC") on July 6, 2026 in connection with their previously announced proposed business combina
PARIS, July 01, 2026 (GLOBE NEWSWIRE) -- newcleo (or the "Company"), a pioneer in advanced modular reactor ("AMR") technology and nuclear fuel manufacturing, today announced it has entered into an agreement to acquire Bonifait Pesage, a French manufacturer of nuclear-grade scales and precision industrial weighing equipment with a strong customer base in the French nuclear ecosystem. The acquisition forms part of newcleo’s vertical integration strategy, pursued since 2023 through the acquisitions of the EPCM and manufacturing companies Fucina, SRS and Rütschi. It will bring critical manufacturing capabilities in-house, secure preferred access to the nuclear-grade weighing equipment require
425 - NewHold Investment Corp. III (0002043699) (Subject)
8-K - NewHold Investment Corp. III (0002043699) (Filer)
425 - NewHold Investment Corp. III (0002043699) (Subject)
SC 13G - NewHold Investment Corp. II (0001852931) (Subject)
SC 13G/A - NewHold Investment Corp. II (0001852931) (Subject)
SC 13G/A - NewHold Investment Corp. II (0001852931) (Subject)
4 - NewHold Investment Corp. III (0002043699) (Issuer)
Newcleo Ltd. ("newcleo" or the "Company") is an established nuclear energy company developing advanced modular, lead-cooled fast reactors (LFRs) and mixed oxide (MOX) nuclear fuel from reprocessed nuclear materials.newcleo ranked as a leading advanced modular reactor company in Europe in an independent review by the OECD Nuclear Energy Agency, reflecting the maturity of its technology, fuel strategy, and project development progress.The proposed business combination is intended to accelerate newcleo's US growth strategy, including leveraging its established European projects as a foundation for execution and deployment.newcleo operates in seven countries, with over 900 employees and generate
NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- newcleo ("newcleo", or the "Company"), a pioneer in advanced modular reactor ("AMR") technology and nuclear fuel manufacturing, today announced the appointments of two accomplished nuclear industry leaders to key positions within its growing U.S. organization. Dustin Greenwood has joined the Company as Vice President of U.S. Operations and Travis Chapman has been appointed Director of U.S. Regulatory Affairs and Licensing. The strategic appointments mark an important milestone in newcleo's U.S. expansion, reinforcing the Company's commitment to advancing next-generation nuclear technologies and establishing a strong operational and regulatory fo